HomeNews & TopicsResearchDiagnosing, assessing and treating long COVID

Diagnosing, assessing and treating long COVID

Published on

About 1.4 million people in Canada have been affected by long COVID after infection, or suspected infection, with SARS-CoV-2. A new trio of practice articles in CMAJ (Canadian Medical Association Journal) aims to help clinicians diagnose, assess and treat people with long COVID.

Long COVID is a systemic condition that can affect most organ systems in the body, defined by symptoms lasting longer than 3 months after a confirmed or suspected SARS-CoV-2 infection. More than 100 symptoms have been reported among people with long COVID, with the most common potentially modifiable symptoms including fatigue, anxiety and depression, shortness of breath, sleep disturbances and heart palpitations.

Treatment of these potentially modifiable symptoms may include a structured and symptom-guided personalized return to activity program to manage fatigue, guideline-directed mental health supports for anxiety and depression, and other interventions to alleviate breathing, sleep and heart issues.

“I believe that the most important thing that we as health care providers can do to support people is to listen and validate their experiences, and to avoid a diagnostic cascade of endless tests and consultations that further tax their limited energy supply,” says Dr. Kieran Quinn, a general internist and palliative care physician, Sinai Health, and an assistant professor, University of Toronto and Institute of Health Policy, Management and Evaluation.

Latest articles

Still managing fax referrals manually?

Despite decades of digital transformation initiatives, one technology still dominates referral intake across hospitals...

New research links brain region to linguistic ability

The cerebellum, typically associated with movement, may also play a key role in reading...

Making Clinical Research a Care Option: How Digital Infrastructure is Expanding Access to Clinical Trials in Canada

Across Canada, there is growing recognition that clinical research should not be viewed as...

Privacy-First AI: How Federated Learning Is Transforming Canadian Cancer Research

Imagine training an AI model on patient data from hospitals in Vancouver, Toronto, and...

More like this

This Canadian startup is decoding the health data revealed in our eyes

If you’ve had a fluorescein angiography (FA), chances are you remember it. The procedure...

A new home for Canada’s largest Cancer Research Tumour Bank

Decades of cancer research — and thousands of patient tumour samples — now have...

Equity-focused study on immigrant kidney disease risk

HN Summary • A new SHN-led study published in BMJ Open reveals significant disparities in...

Shorter duration of antimicrobial therapy in common infections

HN Summary • Growing evidence shows that shorter courses of antibiotics are just as effective...

Global clinical trial exploring potential treatment for sickle cell disease

HN Summary • SHN is leading a global clinical trial testing tebapivat, an investigational oral...

Lithium study yields insights in the fight against HIV

Study in human cells finds low-cost drug keeps virus dormant through an unexpected pathway,...